Crossmark

Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases

Crossref DOI link: https://doi.org/10.1186/s40248-019-0179-2

Published Online: 2019-05-15

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ciancio, Nicola https://orcid.org/0000-0002-8378-0027
Pavone, Mauro

Torrisi, Sebastiano Emanuele

Vancheri, Ada

Sambataro, Domenico

Palmucci, Stefano https://orcid.org/0000-0002-7196-2974
Vancheri, Carlo https://orcid.org/0000-0002-5120-9926
Di Marco, Fabiano

Sambataro, Gianluca https://orcid.org/0000-0001-9933-1202
License Information

Text and Data Mining valid from 2019-05-15
More Information

Article History

Received: 20 November 2018

Accepted: 15 March 2019

First Online: 15 May 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: CV is part of the F. Hoffmann-La Roche Ltd. Scientific board. He has received consulting fees and/or speaker fees from AstraZeneca, BoehringerIngelheim, Chiesi, F. Hoffmann-La Roche Ltd. and Menarini. FDM has participated as a lectures, speaker, and/or advisor in scientific meetings and courses under the sponsorhip of Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, Dompè, Guidotti/Malesci, GlaxoSmithKline, Menarini Group, Novartis, and Zambon, and has received financial suppor for research from Novartis. The authors NC, GS, DS, MP, AV, SET declare that they have no conflict of interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.